Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-08-17Clinical Trial Update: SPECT Study With SB-773812 In Schizophrenic Patients [Phase 1]
A Phase 1 SPECT imaging study of SB-773812 in schizophrenia patients was conducted by GlaxoSmithKline. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2017-08-16Clinical Trial Update: Schizophrenia Study In Adults [Phase 2]
A Phase 2 schizophrenia trial sponsored by GlaxoSmithKline has completed. The update notes the study status but does not provide results in …
-
CLINICAL_TRIALS trial_result · 2017-08-10Clinical Trial Update: NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder [Phase 2]
Phase 2 trial update for NBI-98854 (valbenazine) in tardive dyskinesia in patients with schizophrenia or schizoaffective disorder; results w…
-
CLINICAL_TRIALS trial_result · 2017-08-08Clinical Trial Update: A Healthy Volunteer Study to Assess the Relative Bioavailability of 2 Forms of SB773812 Tablets. [Phase 1]
Phase 1 healthy-volunteer study comparing the relative bioavailability of two tablet forms of SB773812, sponsored by GlaxoSmithKline, in the…
-
CLINICAL_TRIALS trial_result · 2017-08-08Clinical Trial Update: tDCS to Enhance Cognitive Training in Schizophrenia [Phase 1, Phase 2]
Phase 1/2 trials evaluate whether transcranial direct current stimulation (tDCS) can enhance cognitive training in schizophrenia; the study …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-08-07Clinical Trial Update: Early Medication Discontinuation and Long-term Clinical Outcome in FEP
This completed trial update examines how early discontinuation of antipsychotic medication affects long-term outcomes in schizophrenia, incl…
-
CLINICAL_TRIALS trial_result · 2017-08-04Clinical Trial Update: First Time in Human Study With GSK1018921 [Phase 1]
First-in-human Phase 1 study of GSK1018921 in schizophrenia has been completed.
-
CLINICAL_TRIALS trial_result · 2017-08-03Clinical Trial Update: Effects Of The Drug Ketoconazole On How The Body Handles The Drug SB773812 [Phase 1]
A Phase 1 PK interaction study evaluating how ketoconazole affects the pharmacokinetics of the investigational drug SB773812 in schizophreni…
-
CLINICAL_TRIALS trial_result · 2017-08-02Clinical Trial Update: Biomarkers in Schizophrenia [Phase 2]
Phase 2 biomarker study in schizophrenia and schizoaffective disorder; the trial has completed and results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-07-25Clinical Trial Update: Cognitive Remediation Therapy Within a Secure Forensic Setting [NA]
The trial evaluated cognitive remediation therapy in a secure forensic setting for schizophrenia or schizoaffective disorder and is marked a…
-
CLINICAL_TRIALS trial_result · 2017-07-25Clinical Trial Update: Prevention of Weight Gain in Early Psychoses [NA]
A completed clinical trial update examining strategies to prevent weight gain in individuals with early psychosis.
-
CLINICAL_TRIALS trial_result · 2017-07-21Clinical Trial Update: Cognitive Skills Training Using Computer for Patients With Severe Mental Illness [Phase 4]
Phase 4 clinical trial evaluating computer-based cognitive skills training for schizophrenia and schizoaffective disorder has completed.
-
CLINICAL_TRIALS trial_result · 2017-07-21Clinical Trial Update: Treating Social Cognition With Theta Burst Stimulation; a Pilot Sudy [NA]
This entry notes a pilot clinical trial investigating theta-burst stimulation to improve social cognition in schizophrenia. No results or st…
-
CLINICAL_TRIALS trial_result · 2017-07-19Clinical Trial Update: Demographic and Clinical Predictors of Persistence in Patients Treated With Aripiprazole Once-monthly in Italy
A completed Italian study assessing demographic and clinical predictors of persistence in schizophrenia patients treated with aripiprazole o…
-
CLINICAL_TRIALS trial_result · 2017-07-18Clinical Trial Update: Positron Emission Tomography (PET) Study to Describe the Relationship Between Plasma Concentrations and Brain Gly-T1 Occupancy of GSK1018921 Over Time. [Phase 1]
This Phase 1 PET study investigates the relationship between plasma concentrations of GSK1018921 and brain Gly-T1 occupancy in individuals w…
-
CLINICAL_TRIALS trial_result · 2017-07-18Clinical Trial Update: Enhancing Motivation To Quit Smoking In Smokers With Serious Mental Illness [Phase 1]
Phase 1 clinical trial at Rutgers explored strategies to enhance motivation to quit smoking in individuals with schizophrenia or schizoaffec…
-
CLINICAL_TRIALS trial_result · 2017-07-17Clinical Trial Update: Study to Evaluate D2 Receptor Occupancy Following Single Intravenous Administration of ATI-9242 [Phase 1]
Braeburn Pharmaceuticals reports the completed Phase 1 study evaluating D2 receptor occupancy after a single intravenous dose of ATI-9242 in…
-
CLINICAL_TRIALS trial_result · 2017-07-14Clinical Trial Update: Cognitive Behavioural Therapy- Social Functioning In Adolescence With Recent Onset Schizophrenia [NA]
A clinical trial evaluating Cognitive Behavioral Therapy to improve social functioning in adolescents with recent-onset schizophrenia has co…
-
CLINICAL_TRIALS trial_result · 2017-07-13Clinical Trial Update: Pharmacokinetics and Tolerability Study of Risperidone ISM® in Schizophrenia [Phase 2]
Phase 2 pharmacokinetics and tolerability study of Risperidone ISM in schizophrenia completed; results posted July 2017.
-
CLINICAL_TRIALS trial_result · 2017-07-07Clinical Trial Update: First Time in Human Study (FTIH) With Positron Emission Tomography (PET) [Phase 1]
A first-in-human Phase 1 study using PET imaging for schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2017-07-07Clinical Trial Update: Daily Intranasal Oxytocin for Childhood-Onset Schizophrenia [Phase 1, Phase 2]
This ClinicalTrials.gov update reports that the Phase 1/2 study of daily intranasal oxytocin for childhood-onset schizophrenia has been term…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Effects of Antipsychotics on Eating and Food Craving in People With Schizophrenia
A completed clinical trial investigating how antipsychotic medications influence eating behavior and food cravings in people with schizophre…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Risk Perception in Drug-Dependent Adults With and Without Schizophrenia
A completed clinical trial update from NIDA examining risk perception in adults with cocaine or cannabis use disorders, comparing those with…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Timing of Voluntary Movement in Patients With Schizophrenia
A completed clinical trial update examining the timing of voluntary movement in patients with schizophrenia.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: fMRI Study of Nicotinic Effect on Neurophysiology of Schizophrenia
This completed NIDA-funded fMRI study examined the effects of nicotinic stimulation on neurophysiology in individuals with schizophrenia and…